Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Diagnostic Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Barrett Esophagus 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Pulmonary Nodules 1 Lung Diseases 1 Hypoxia 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Breast Neoplasms 1 Breast Neoplasm Female 1 Adenocarcinoma of Lung 1 Adenocarcinoma 1

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03217539 2018-02-07

WE

Dalarna County Council, Sweden

Phase NA Completed

133,065 enrolled

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡